Revenue
-
Net Income
-$9.2M
▼ 56.3% YoY
EPS
$-1.09
▼ 22.5% YoY
Cash
$3.0M
▼ 68.7% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Korman Tyler Paz Chief Scientific Officer | Sell | Apr 9, 2026 | 750 | $10.53 | $8K | Form 4 ↗ |
Korman Tyler Paz Chief Scientific Officer | Sell | Apr 8, 2026 | 750 | $10.04 | $8K | Form 4 ↗ |
Perriman Damien Alan Chief Commercial Officer | Grant | Apr 1, 2026 | 62.8K | $0.00 | $0 | Form 4 ↗ |
Perriman Damien Alan Chief Commercial Officer | Grant | Apr 1, 2026 | 8.9K | $8.44 | $75K | Form 4 ↗ |
Opgenorth Paul Hideo Vice President, Development | Grant | Apr 1, 2026 | 4.0K | $8.44 | $34K | Form 4 ↗ |
Nawaz Fouad Vice President- Finance | Grant | Apr 1, 2026 | 6.0K | $8.44 | $51K | Form 4 ↗ |
Korman Tyler Paz Chief Scientific Officer | Grant | Apr 1, 2026 | 5.3K | $8.44 | $45K | Form 4 ↗ |